Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university

Abstract Background We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods Using an online questionnaire, this cross-sectional study surveyed 346 female und...

Full description

Saved in:
Bibliographic Details
Main Authors: Bridget Atuhaire, Laban Muteebwa, Racheal Nabunya, Richard Muhindo, Tom Denis Ngabirano, Charles Peter Osingada, Patience A. Muwanguzi
Format: Article
Language:English
Published: BMC 2024-12-01
Series:AIDS Research and Therapy
Subjects:
Online Access:https://doi.org/10.1186/s12981-024-00686-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850100557828587520
author Bridget Atuhaire
Laban Muteebwa
Racheal Nabunya
Richard Muhindo
Tom Denis Ngabirano
Charles Peter Osingada
Patience A. Muwanguzi
author_facet Bridget Atuhaire
Laban Muteebwa
Racheal Nabunya
Richard Muhindo
Tom Denis Ngabirano
Charles Peter Osingada
Patience A. Muwanguzi
author_sort Bridget Atuhaire
collection DOAJ
description Abstract Background We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18–25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors. Results More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year. Conclusion Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students’ studies to increase awareness and acceptance.
format Article
id doaj-art-c8e4a9d8448b42b7bf480b44e2f05fc7
institution DOAJ
issn 1742-6405
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series AIDS Research and Therapy
spelling doaj-art-c8e4a9d8448b42b7bf480b44e2f05fc72025-08-20T02:40:15ZengBMCAIDS Research and Therapy1742-64052024-12-012111610.1186/s12981-024-00686-5Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan universityBridget Atuhaire0Laban Muteebwa1Racheal Nabunya2Richard Muhindo3Tom Denis Ngabirano4Charles Peter Osingada5Patience A. Muwanguzi6Department of Nursing, School of Health Sciences, College of Health Sciences, Makerere UniversitySchool of Medicine, College of Health Sciences, Makerere UniversityAfrican Center for Health Equity Research and InnovationDepartment of Nursing, School of Health Sciences, College of Health Sciences, Makerere UniversityDepartment of Nursing, School of Health Sciences, College of Health Sciences, Makerere UniversitySchool of Nursing, University of Minnesota School of NursingDepartment of Nursing, School of Health Sciences, College of Health Sciences, Makerere UniversityAbstract Background We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18–25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors. Results More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year. Conclusion Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students’ studies to increase awareness and acceptance.https://doi.org/10.1186/s12981-024-00686-5Long-acting cabotegravirPre-exposure prophylaxisStudentsWillingness
spellingShingle Bridget Atuhaire
Laban Muteebwa
Racheal Nabunya
Richard Muhindo
Tom Denis Ngabirano
Charles Peter Osingada
Patience A. Muwanguzi
Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
AIDS Research and Therapy
Long-acting cabotegravir
Pre-exposure prophylaxis
Students
Willingness
title Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
title_full Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
title_fullStr Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
title_full_unstemmed Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
title_short Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
title_sort brief communication factors associated with willingness to use long acting injectable cabotegravir for hiv pre exposure prophylaxis prep among female undergraduate students at a ugandan university
topic Long-acting cabotegravir
Pre-exposure prophylaxis
Students
Willingness
url https://doi.org/10.1186/s12981-024-00686-5
work_keys_str_mv AT bridgetatuhaire briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity
AT labanmuteebwa briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity
AT rachealnabunya briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity
AT richardmuhindo briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity
AT tomdenisngabirano briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity
AT charlespeterosingada briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity
AT patienceamuwanguzi briefcommunicationfactorsassociatedwithwillingnesstouselongactinginjectablecabotegravirforhivpreexposureprophylaxisprepamongfemaleundergraduatestudentsataugandanuniversity